Skip directly to search Skip directly to A to Z list Skip directly to site content Skip directly to page options
CDC Home

Safe Healthcare

Hosted by CDC’s Division of Healthcare Quality Promotion

Share
Compartir

Selected Category: Healthcare-associated infections

$10 Million Dollars to Save Countless Lives

Categories: Antibiotic use, BSIs, CLABSI, Healthcare-associated infections, MRSA

John A. Jernigan, MD, MS

John A. Jernigan, MD, MS

Author – John Jernigan, M.D.
CDC’s Division of Healthcare Quality Promotion

Today, I am proud to announce that my office is awarding $10 million for new research to five academic medical centers as part of our Prevention Epicenter grant program.  This program supports efforts to develop and test innovative approaches to reducing infections in healthcare settings. It is more than research – we are taking novel discoveries and translating them into clinical practice.  These efforts save lives.

We founded the Prevention Epicenter program in 1997.  CDC staff work closely with academic investigators to discover solutions, and refine them so they can work to prevent infections for all healthcare settings.  It has been thrilling over the years to watch the innovations in infection prevention that have come out of this program.  Some of our biggest breakthroughs in infection prevention and strategies to save lives have been rooted in research of the Prevention Epicenter program.

Some of the breakthroughs that I have been particularly proud of are:

  • using skin antiseptic in routine bathing of patients to prevent HAIs, including the use of chlorhexidine to prevent Methicillin-Resistant Staphylococcus Aureus (MRSA) infections,
  • developing cutting edge methods for detecting HAIs such as using computer algorithms to detect  bloodstream infections, and
  • pioneering a new method for determining the effectiveness of HAI prevention strategies among a large group of hospitals. 

Infections in ICUs Plummeting, Too Many Remain in Hospitals and Dialysis Clinics

Categories: Antimicrobial Resistance, BSIs, CLABSI, Dialysis, Gram negatives, Healthcare-associated infections, MRSA, NHSN

Arjun Srinivasan, MD

Arjun Srinivasan, MD

Author – Arjun Srinivasan, MD
CDC’s Division of Healthcare Quality Promotion

As you know, bloodstream infections in patients with central lines can be deadly, killing as many as 1 in 4 patients who gets them. The newest edition of the CDC Vital Signs reports a major decrease in central-line associated bloodstream infections (CLABSIs) in intensive care unit (ICU) patients. This is an important triumph for patient safety and brings me a renewed sense of hope toward the elimination of HAIs. It also solidifies an expectation that infection prevention should be a priority in order to improve the safety of patients.

While progress is promising, about 60,000 bloodstream infections in patients with central lines still occurred outside of ICUs and in dialysis centers, according to our report. Much of this is preventable harm. We have to make every effort to ensure patients are protected in all healthcare facilities, all the time. So, how do we do that?
The good news is that everyone can contribute to preventing CLABSIs, no matter where the patient receives care.

Dr. Peter Pronovost on CDC’s Vital Signs Report: Why Success was Possible

Categories: Antimicrobial Resistance, BSIs, CLABSI, Dialysis, Healthcare-associated infections, MRSA, NHSN

Dr. Peter Pronovost on CDC’s Vital Signs Report: Why Success was Possible

Dr. Peter Pronovost on CDC’s Vital Signs Report: Why Success was Possible

Dr. Peter Pronovost, Johns Hopkins University, provides three video commentaries on CDC’s recent Vital Signs report on central line-associated bloodstream infections in hospitals and dialysis facilities. Dr. Pronovost’s commentary is provided below. Click on the video to watch

Transcript: Why was success possible?

Success was possible because many groups partnered and worked collaboratively.

On the national level, the CDC, AHRQ, CMS, and Health and Human Services all worked together.

At the state level, state hospital associations, state health departments and quality improvement organizations united forces.

And within hospitals, ICU clinicians, infection preventionists, and hospital managers worked together.

Dr. Peter Pronovost on CDC’s Vital Signs Report: How we can work together to leverage our success

Categories: Antimicrobial Resistance, BSIs, CLABSI, Dialysis, Healthcare-associated infections, MRSA, NHSN

Dr. Peter Pronovost on CDC’s Vital Signs Report: How we can work together to leverage our success

Dr. Peter Pronovost on CDC’s Vital Signs Report: How we can work together to leverage our success

Dr. Peter Pronovost, Johns Hopkins University, provides three video commentaries on CDC’s recent Vital Signs report on central line-associated bloodstream infections in hospitals and dialysis facilities. Dr. Pronovost’s commentary is provided below. Click on the video to watch.

Transcript: How we can work together to leverage our success

So what can we do:

“US government – work together to mature the science and develop safety programs – programs with clear evidence for best practices, programs with measures that clinicians believe are valid, programs that deliver results, programs that help clinicians believe they can truly make a difference.

States – coordinate efforts, create infrastructure to implement the science, provide technical support to hospitals seeking to measure and reduce infections, and ensure that all hospitals that have not eliminated CLABSI participate in the national program called On the CUSP: Stop BSI.

Dr. Peter Pronovost on CDC’s Vital Signs Report: Where do we go from here?

Categories: Antimicrobial Resistance, BSIs, CLABSI, Dialysis, Healthcare-associated infections, MRSA, NHSN

Dr. Peter Pronovost on CDC’s Vital Signs Report: Where do we go from here?

Dr. Peter Pronovost on CDC’s Vital Signs Report: Where do we go from here?

Dr. Peter Pronovost, Johns Hopkins University, provides three video commentaries on CDC’s recent Vital Signs report on central line-associated bloodstream infections in hospitals and dialysis facilities. Dr. Pronovost’s commentary is provided below. Click on the video to watch.

Transcript: Where do we go from here?

“We must ensure that all patients in ICUs receive best practices. We have seen dramatic reductions in infections in all types of ICUs – teaching and community, large and small, urban and rural. Yet the results are patchy. Some ICUs remain with high CLABSI rates.

We must apply these lessons to reduce other types of preventable harm such as ventilator-associated pneumonia.

Older Posts Newer Posts

Pages in this Blog
 
USA.gov: The U.S. Government's Official Web PortalDepartment of Health and Human Services
Centers for Disease Control and Prevention   1600 Clifton Rd. Atlanta, GA 30333, USA
800-CDC-INFO (800-232-4636) TTY: (888) 232-6348 - Contact CDC–INFO
A-Z Index
  1. A
  2. B
  3. C
  4. D
  5. E
  6. F
  7. G
  8. H
  9. I
  10. J
  11. K
  12. L
  13. M
  14. N
  15. O
  16. P
  17. Q
  18. R
  19. S
  20. T
  21. U
  22. V
  23. W
  24. X
  25. Y
  26. Z
  27. #